| Suppression of extravillous trophoblast vascular endothelial growth factor expression and uterine spiral artery invasion by estrogen during early baboon pregnancy. | |
| | |
MedLine Citation:
|
PMID: 18566115 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We have shown that advancing the increase in maternal serum estrogen levels from the second to the first third of baboon pregnancy suppressed extravillous cytotrophoblast (EVT) spiral artery invasion. Because vascular endothelial growth factor (VEGF) promotes EVT invasion, the present study determined whether EVT VEGF expression is altered by prematurely elevating estrogen in early pregnancy. Placental basal plate was obtained on d 60 of gestation (term is 184 d) from baboons treated daily on d 25-59 with estradiol (0.35 mg/d sc), which increased maternal peripheral serum estradiol levels 3-fold above normal. Overall percentage of uterine arteries (25 to more than 100 microm in diameter) invaded by EVT assessed by image analysis in untreated baboons (29.11+/-5.78%) was decreased 4.5-fold (P<0.001) by prematurely elevating estrogen (6.55+/-1.83%). VEGF mRNA levels in EVT isolated by laser capture microdissection from the anchoring villi of untreated baboons (6.77+/-2.20) were decreased approximately 5-fold (P<0.05, ANOVA) by estradiol (1.37+/-0.29). Uterine vein serum levels of the truncated soluble fms-like receptor, which controls VEGF bioavailability, in untreated baboons (403+/-37 pg/ml) were increased 3-fold (P<0.01) by estrogen treatment (1127+/-197 pg/ml). Thus, placental EVT expression of VEGF mRNA was decreased and serum soluble truncated fms-like receptor levels increased in baboons in which EVT invasion of the uterine spiral arteries was suppressed by advancing the rise in estrogen from the second to the first third of pregnancy. We suggest that VEGF mediates the decline in EVT vessel invasion induced by estrogen in early primate pregnancy. |
| | |
Authors:
|
Thomas W Bonagura; Gerald J Pepe; Allen C Enders; Eugene D Albrecht |
Related Documents
:
|
15314775 - Serum alkaline phosphatase in pregnant mares. 662225 - Endogenous creatinine clearance during pregnancy. ii. variations in normal standards ba... 3369475 - Effects of chronic renal failure and hemodialysis on hormonal evaluation of pregnancy. 15361555 - Inhibin, activin, follistatin, activin receptors and beta-glycan gene expression in the... 23262935 - Independent relation of maternal prenatal factors to early childhood obesity in the off... 12606235 - Inaccuracy in cervical dilatation assessment and the progress of labour monitoring. |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural Date: 2008-06-19 |
Journal Detail:
|
Title: Endocrinology Volume: 149 ISSN: 0013-7227 ISO Abbreviation: Endocrinology Publication Date: 2008 Oct |
Date Detail:
|
Created Date: 2008-09-23 Completed Date: 2008-11-04 Revised Date: 2013-03-05 |
Medline Journal Info:
|
Nlm Unique ID: 0375040 Medline TA: Endocrinology Country: United States |
Other Details:
|
Languages: eng Pagination: 5078-87 Citation Subset: AIM; IM |
Affiliation:
|
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Maryland School of Medicine, Bressler Research Laboratories 11-019, 655 West Baltimore Street, Baltimore, Maryland 21201, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Body Weight Estrogens / blood*, pharmacology Female Gestational Age Immunohistochemistry Organ Size Papio anubis Pregnancy Pregnancy, Animal / physiology* RNA, Messenger / metabolism Solubility Trophoblasts / physiology* Uterus / blood supply*, cytology Vascular Endothelial Growth Factor A / genetics* Vascular Endothelial Growth Factor Receptor-1 / blood, genetics* |
| Grant Support | |
ID/Acronym/Agency:
|
R01 HD013294-28/HD/NICHD NIH HHS; R01 HD013294-30/HD/NICHD NIH HHS; R01 HD13294/HD/NICHD NIH HHS; U54 HD36207/HD/NICHD NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Estrogens; 0/RNA, Messenger; 0/Vascular Endothelial Growth Factor A; EC 2.7.10.1/Vascular Endothelial Growth Factor Receptor-1 |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Alterations in RFamide-related peptide expression are coordinated with the preovulatory luteinizing ...
Next Document: Steroid receptor coactivator-1 from brain physically interacts differentially with steroid receptor ...